Research graph
References from miR‐214‐3p and NCKAP1: A microglial functional dimension of Alzheimer's progression. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1083/jcb.201709069
10.1083/jcb.201709069 · External reference
10.1038/s41582‐020‐00435‐y
10.1038/s41582‐020‐00435‐y · External reference
Meta‐analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
10.1038/ng.2802 · 2013 · External reference
New insights into the genetic etiology of Alzheimer's disease and related dementias
10.1038/s41588-022-01024-z · 2022 · External reference
10.1523/jneurosci.0616‐08.2008
10.1523/jneurosci.0616‐08.2008 · External reference
10.3389/fncel.2013.00006
10.3389/fncel.2013.00006 · External reference
10.1007/s12035‐023‐03339‐2
10.1007/s12035‐023‐03339‐2 · External reference
10.1136/jnnp‐2024‐335177
10.1136/jnnp‐2024‐335177 · External reference
10.3389/fnmol.2018.00144
10.3389/fnmol.2018.00144 · External reference
10.1186/s13024‐019‐0314‐8
10.1186/s13024‐019‐0314‐8 · External reference
10.1186/s13024‐025‐00867‐4
10.1186/s13024‐025‐00867‐4 · External reference
10.1126/science.aad8373
10.1126/science.aad8373 · External reference
10.1155/2018/2530414
10.1155/2018/2530414 · External reference
10.1038/s41582‐025‐01162‐y
10.1038/s41582‐025‐01162‐y · External reference
10.1186/s12974‐025‐03546‐9
10.1186/s12974‐025‐03546‐9 · External reference
10.1002/alz.13859
10.1002/alz.13859 · External reference
10.3988/jcn.2025.0218
10.3988/jcn.2025.0218 · External reference
Lecanemab in early Alzheimer's disease
10.1056/nejmoa2212948 · 2023 · External reference
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER‐ALZ 2 randomized clinical trial
10.1001/jama.2023.13239 · 2023 · External reference
Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology
10.1001/jamaneurol.2023.5319 · 2024 · External reference
10.1001/jama.2020.12134
10.1001/jama.2020.12134 · External reference
10.1001/jamaneurol.2021.3671
10.1001/jamaneurol.2021.3671 · External reference
10.1001/jamaneurol.2016.6117
10.1001/jamaneurol.2016.6117 · External reference
Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression
10.1002/alz.13450 · 2024 · External reference
10.1093/brain/awaa286
10.1093/brain/awaa286 · External reference
10.1126/science.8346443
10.1126/science.8346443 · External reference
10.1038/s41586‐024‐07185‐7
10.1038/s41586‐024‐07185‐7 · External reference
Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal‐network activity
10.1016/j.stem.2022.07.005 · 2022 · External reference
10.3389/fncel.2015.00184
10.3389/fncel.2015.00184 · External reference
10.1038/nrm2069
10.1038/nrm2069 · External reference
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune‐inflammatory Modulation
10.12779/dnd.2019.18.2.33 · 2019 · External reference
10.1016/j.jalz.2018.02.018
10.1016/j.jalz.2018.02.018 · External reference
10.1007/bf03028618
10.1007/bf03028618 · External reference
10.1002/alz.14050
10.1002/alz.14050 · External reference
10.1016/j.jalz.2012.01.005
10.1016/j.jalz.2012.01.005 · External reference
10.1016/j.jalz.2015.02.004
10.1016/j.jalz.2015.02.004 · External reference
10.1038/s41593‐018‐0334‐7
10.1038/s41593‐018‐0334‐7 · External reference
10.1126/scitranslmed.aai7635
10.1126/scitranslmed.aai7635 · External reference
10.15252/emmm.201606370
10.15252/emmm.201606370 · External reference
10.5966/sctm.2015‐0217
10.5966/sctm.2015‐0217 · External reference
10.1038/s41467‐019‐08729‐6
10.1038/s41467‐019‐08729‐6 · External reference
A gene network regulating lysosomal biogenesis and function
10.1126/science.1174447 · 2009 · External reference
10.1016/j.jalz.2015.05.004
10.1016/j.jalz.2015.05.004 · External reference
10.1186/s13024‐016‐0071‐x
10.1186/s13024‐016‐0071‐x · External reference
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
10.15252/emmm.201506123 · 2016 · External reference
Millipore xMap(R) Luminex (HATMAG‐68K): an accurate and cost‐effective method for evaluating Alzheimer's. biomarkers in cerebrospinal Fluid
10.3389/fpsyt.2021.716686 · 2021 · External reference
10.1002/acn3.51670
10.1002/acn3.51670 · External reference
10.1038/nature09623
10.1038/nature09623 · External reference
10.1038/s41598‐025‐90232‐8
10.1038/s41598‐025‐90232‐8 · External reference
10.1126/sciadv.abo5600
10.1126/sciadv.abo5600 · External reference
10.3233/jad‐230199
10.3233/jad‐230199 · External reference
10.1038/nature21029
10.1038/nature21029 · External reference
10.1006/geno.1999.6053
10.1006/geno.1999.6053 · External reference
10.1016/s0378‐1119(01)00521‐2
10.1016/s0378‐1119(01)00521‐2 · External reference
10.1016/j.biopha.2024.116123
10.1016/j.biopha.2024.116123 · External reference
10.3389/fnagi.2021.700959
10.3389/fnagi.2021.700959 · External reference
10.1007/s00018‐023‐04775‐y
10.1007/s00018‐023‐04775‐y · External reference
10.1038/s41598‐022‐21920‐y
10.1038/s41598‐022‐21920‐y · External reference
10.1016/j.cell.2017.05.018
10.1016/j.cell.2017.05.018 · External reference
The TREM2‐APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases
10.1016/j.immuni.2017.08.008 · 2017 · External reference
